Literature DB >> 6869800

Determination of pseudouridine and other nucleosides in human blood serum by high-performance liquid chromatography.

A Colonna, T Russo, F Esposito, F Salvatore, F Cimino.   

Abstract

A specific, sensitive, and rapid method to measure pseudouridine in human blood serum is described. The method is based on the following steps: (i) deproteinization of serum samples by filtration on membrane cones or by acetonitrile; (ii) purification of nucleosides and concentration of the sample by affinity chromatography on phenylboronate gel followed by lyophilization; and (iii) separation of nucleosides and their quantitation by reverse-phase high-performance liquid chromatography. The pseudouridine mean value in 30 normal subjects was 2.52 +/- 0.28 nmol/ml. The procedure also allows the identification of inosine, uridine, guanosine, and adenosine. Nevertheless, the presence in human blood serum of enzymatic activities which convert adenosine to inosine and cytidine to uridine prevents the precise quantitation of these nucleosides. All the compounds were identified by comparing their retention times and absorbance ratios (A280/A254) with those of pure compounds, as well as by cochromatography.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6869800     DOI: 10.1016/0003-2697(83)90644-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Efficiency of purine utilization by Helicobacter pylori: roles for adenosine deaminase and a NupC homolog.

Authors:  Erica F Miller; Soumya Vaish; Robert J Maier
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

2.  From Discovery to Translation: Characterization of C-Mannosyltryptophan and Pseudouridine as Markers of Kidney Function.

Authors:  Peggy Sekula; Katja Dettmer; Franziska C Vogl; Wolfram Gronwald; Lisa Ellmann; Robert P Mohney; Kai-Uwe Eckardt; Karsten Suhre; Gabi Kastenmüller; Peter J Oefner; Anna Köttgen
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.